148 related articles for article (PubMed ID: 31399820)
1. Comparison of Tissue and Blood Concentrations of Oxaliplatin Administrated by Different Modalities of Intraperitoneal Chemotherapy.
Giger-Pabst U; Bucur P; Roger S; Falkenstein TA; Tabchouri N; Le Pape A; Lerondel S; Demtröder C; Salamé E; Ouaissi M
Ann Surg Oncol; 2019 Dec; 26(13):4445-4451. PubMed ID: 31399820
[TBL] [Abstract][Full Text] [Related]
2. In Vivo Feasibility of Electrostatic Precipitation as an Adjunct to Pressurized Intraperitoneal Aerosol Chemotherapy (ePIPAC).
Kakchekeeva T; Demtröder C; Herath NI; Griffiths D; Torkington J; Solaß W; Dutreix M; Reymond MA
Ann Surg Oncol; 2016 Dec; 23(Suppl 5):592-598. PubMed ID: 26842487
[TBL] [Abstract][Full Text] [Related]
3. A phase I dose-escalation study of oxaliplatin delivered via a laparoscopic approach using pressurised intraperitoneal aerosol chemotherapy for advanced peritoneal metastases of gastrointestinal tract cancers.
Dumont F; Passot C; Raoul JL; Kepenekian V; Lelièvre B; Boisdron-Celle M; Hiret S; Senellart H; Pein F; Blanc-Lapierre A; Raimbourg J; Thibaudeau E; Glehen O;
Eur J Cancer; 2020 Nov; 140():37-44. PubMed ID: 33039812
[TBL] [Abstract][Full Text] [Related]
4. Systemic Pharmacokinetics of Oxaliplatin After Intraperitoneal Administration by Electrostatic Pressurized Intraperitoneal Aerosol Chemotherapy (ePIPAC) in Patients with Unresectable Colorectal Peritoneal Metastases in the CRC-PIPAC Trial.
Lurvink RJ; Tajzai R; Rovers KP; Wassenaar ECE; Moes DAR; Pluimakers G; Boerma D; Burger JWA; Nienhuijs SW; de Hingh IHJT; Deenen MJ
Ann Surg Oncol; 2021 Jan; 28(1):265-272. PubMed ID: 32572849
[TBL] [Abstract][Full Text] [Related]
5. High pressure enhances the effect of hyperthermia in intraperitoneal chemotherapy with oxaliplatin: an experimental study.
Facy O; Al Samman S; Magnin G; Ghiringhelli F; Ladoire S; Chauffert B; Rat P; Ortega-Deballon P
Ann Surg; 2012 Dec; 256(6):1084-8. PubMed ID: 22634898
[TBL] [Abstract][Full Text] [Related]
6. Pressurized IntraPeritoneal Aerosol Chemotherapy with one minute of electrostatic precipitation (ePIPAC) is feasible, but the histological tumor response in peritoneal metastasis is insufficient.
Graversen M; Detlefsen S; Ellebaek SB; Fristrup C; Pfeiffer P; Mortensen MB
Eur J Surg Oncol; 2020 Jan; 46(1):155-159. PubMed ID: 31493986
[TBL] [Abstract][Full Text] [Related]
7. Phase I/II study of oxaliplatin dose escalation via a laparoscopic approach using pressurized aerosol intraperitoneal chemotherapy (PIPOX trial) for nonresectable peritoneal metastases of digestive cancers (stomach, small bowel and colorectal): Rationale and design.
Dumont F; Senellart H; Pein F; Campion L; Glehen O; Goere D; Pocard M; Thibaudeau E
Pleura Peritoneum; 2018 Sep; 3(3):20180120. PubMed ID: 30911664
[TBL] [Abstract][Full Text] [Related]
8. Establishment of a rat ovarian peritoneal metastasis model to study pressurized intraperitoneal aerosol chemotherapy (PIPAC).
Van de Sande L; Willaert W; Cosyns S; De Clercq K; Shariati M; Remaut K; Ceelen W
BMC Cancer; 2019 May; 19(1):424. PubMed ID: 31064330
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics of oxaliplatin during open versus laparoscopically assisted heated intraoperative intraperitoneal chemotherapy (HIPEC): an experimental study.
Gesson-Paute A; Ferron G; Thomas F; de Lara EC; Chatelut E; Querleu D
Ann Surg Oncol; 2008 Jan; 15(1):339-44. PubMed ID: 17943387
[TBL] [Abstract][Full Text] [Related]
10. Chemosensitivity of various peritoneal cancer cell lines to HIPEC and PIPAC: comparison of an experimental duplex drug to standard drug regimens in vitro.
Weinreich J; Struller F; Sautkin I; Giuashvili S; Reymond M; Königsrainer A; Schott TC
Invest New Drugs; 2019 Jun; 37(3):415-423. PubMed ID: 30019100
[TBL] [Abstract][Full Text] [Related]
11. Exploring the Spatial Drug Distribution Pattern of Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC).
Khosrawipour V; Khosrawipour T; Diaz-Carballo D; Förster E; Zieren J; Giger-Pabst U
Ann Surg Oncol; 2016 Apr; 23(4):1220-4. PubMed ID: 26553440
[TBL] [Abstract][Full Text] [Related]
12. Experimental pharmacokinetics evaluation of chemotherapy delivery by PIPAC for colon cancer: first evidence for efficacy.
Eveno C; Haidara A; Ali I; Pimpie C; Mirshahi M; Pocard M
Pleura Peritoneum; 2017 Jun; 2(2):103-109. PubMed ID: 30911638
[TBL] [Abstract][Full Text] [Related]
13. Pressurized Intra-peritoneal Aerosol Chemotherapy (PIPAC)
Khosrawipour V; Mikolajczyk A; Schubert J; Khosrawipour T
Anticancer Res; 2018 Jun; 38(6):3447-3452. PubMed ID: 29848695
[TBL] [Abstract][Full Text] [Related]
14. Pressurized intraperitoneal aerosol chemotherapy (PIPAC) might increase the risk of anastomotic leakage compared to HIPEC: an experimental study.
Tavernier C; Passot G; Vassal O; Allaouchiche B; Decullier E; Bakrin N; Alyami M; Davigo A; Bonnet JM; Louzier V; Paquet C; Glehen O; Kepenekian V
Surg Endosc; 2020 Jul; 34(7):2939-2946. PubMed ID: 31456025
[TBL] [Abstract][Full Text] [Related]
15. PIPAC versus HIPEC: cisplatin spatial distribution and diffusion in a swine model.
Davigo A; Passot G; Vassal O; Bost M; Tavernier C; Decullier E; Bakrin N; Alyami M; Bonnet JM; Louzier V; Paquet C; Allaouchiche B; Glehen O; Kepenekian V
Int J Hyperthermia; 2020; 37(1):144-150. PubMed ID: 32003300
[No Abstract] [Full Text] [Related]
16. PIPAC-OX: A Phase I Study of Oxaliplatin-Based Pressurized Intraperitoneal Aerosol Chemotherapy in Patients with Peritoneal Metastases.
Kim G; Tan HL; Sundar R; Lieske B; Chee CE; Ho J; Shabbir A; Babak MV; Ang WH; Goh BC; Yong WP; Wang L; So JBY
Clin Cancer Res; 2021 Apr; 27(7):1875-1881. PubMed ID: 33148667
[TBL] [Abstract][Full Text] [Related]
17. Oxaliplatin use in pressurized intraperitoneal aerosol chemotherapy (PIPAC) is safe and effective: A multicenter study.
Sgarbura O; Hübner M; Alyami M; Eveno C; Gagnière J; Pache B; Pocard M; Bakrin N; Quénet F
Eur J Surg Oncol; 2019 Dec; 45(12):2386-2391. PubMed ID: 31092362
[TBL] [Abstract][Full Text] [Related]
18. Severe peritoneal sclerosis after repeated pressurized intraperitoneal aerosol chemotherapy with oxaliplatin (PIPAC OX): report of two cases and literature survey.
Graversen M; Detlefsen S; Pfeiffer P; Lundell L; Mortensen MB
Clin Exp Metastasis; 2018 Mar; 35(3):103-108. PubMed ID: 29705882
[TBL] [Abstract][Full Text] [Related]
19. Repetitive electrostatic pressurised intraperitoneal aerosol chemotherapy (ePIPAC) with oxaliplatin as a palliative monotherapy for isolated unresectable colorectal peritoneal metastases: protocol of a Dutch, multicentre, open-label, single-arm, phase II study (CRC-PIPAC).
Rovers KP; Lurvink RJ; Wassenaar EC; Kootstra TJ; Scholten HJ; Tajzai R; Deenen MJ; Nederend J; Lahaye MJ; Huysentruyt CJ; van 't Erve I; Fijneman RJ; Constantinides A; Kranenburg O; Los M; Thijs AM; Creemers GM; Burger JW; Wiezer MJ; Boerma D; Nienhuijs SW; de Hingh IH
BMJ Open; 2019 Jul; 9(7):e030408. PubMed ID: 31352425
[TBL] [Abstract][Full Text] [Related]
20. Pressurized intraperitoneal aerosol chemotherapy (PIPAC) as a neoadjuvant therapy before cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.
Girshally R; Demtröder C; Albayrak N; Zieren J; Tempfer C; Reymond MA
World J Surg Oncol; 2016 Sep; 14(1):253. PubMed ID: 27678344
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
